top of page

Designed for Market Leadership ​

Targeting a FREE position with unmatched risk/benefit ratio compared to current best selling products​

Targeting a Massive Opportunity​

Set to disrupt a €39bn market, fueled by megatrends like demand for natural, safer solutions, increased respiratory health awareness, and a shift toward self-care.

Market Positioning



We actively seek strategic partners for the commercialization of BREATHOX® in the EU and global licensing partners for the Osmovir platform as part of our global growth strategy.


Seeking BREATHOX® distribution partners in the EU or consumer health companies seeking line extensions.

Osmovir® Licensing

Seeking strategic global and regional licensing partnerships, allowing partners to launch line extensions in their own brands.

bottom of page